Shrinkage of uterine fibroids during therapy with goserelin (Zoladex ): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot
- 1 July 1987
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 48 (1) , 45-51
- https://doi.org/10.1016/s0015-0282(16)59288-7
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- SUPPRESSION OF OVARIAN ACTIVITY BY ZOLADEX DEPOT (ICI 118630), A LONG‐ACTING LUTEINIZING HORMONE RELEASING HORMONE AGONIST ANALOGUEClinical Endocrinology, 1987
- GOSERELIN THERAPY BEFORE SURGERY FOR UTERINE FIBROIDSThe Lancet, 1987
- Toward Removing Uterine Fibroids without Surgery: Subcutaneous Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Commencing in the Luteal PhaseJournal of Clinical Endocrinology & Metabolism, 1986
- Long-acting gonadotropin hormone-releasing hormone analogused to treat uteriFertility and Sterility, 1986
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985
- A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogueAmerican Journal of Obstetrics and Gynecology, 1983
- PULSATILE SECRETION OF LH, FSH, PROLACTIN, OESTRADIOL AND PROGESTERONE DURING THE HUMAN MENSTRUAL CYCLEClinical Endocrinology, 1982
- Leiomyomas: Steroid receptor contentAmerican Journal of Obstetrics and Gynecology, 1982
- The direct radioimmunoassay of oestrogen glucuronides in human female urineBiochemical Journal, 1979
- REDUCTION OF NON-SPECIFIC SERUM RESPONSES IN HUMAN PITUITARY GONADOTROPHIN RADIOIMMUNOASSAYSJournal of Endocrinology, 1979